Skip to Main Content

Author Details

Hyung J Chun
Yale Cardiovascular Research Center, Yale University School of Medicine
1996
74
33
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36166408BMPR1A promotes ID2-ZEB1 interaction to suppress excessive endothelial to mesenchymal transition.Cardiovasc Res2023
37091121Proteomic profiling demonstrates inflammatory and endotheliopathy signatures associated with impaired cardiopulmonary exercise hemodynamic profile in Post Acute Sequelae of SARS-CoV-2 infection (PASC) syndrome.Pulm Circ2023
35259186Association of renalase with clinical outcomes in hospitalized patients with COVID-19.PLoS One2022
36193076Epidermal Growth Factor Receptor Inhibition Is Protective in Hyperoxia-Induced Lung Injury.Oxid Med Cell Longev2022
36384975LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis.Biol Direct2022
34901896Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era.Lancet Microbe2022
35108537Macrophage IL-1β promotes arteriogenesis by autocrine STAT3- and NF-κB-mediated transcription of pro-angiogenic VEGF-A.Cell Rep2022
33469595Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis.medRxiv2021
33655244Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.bioRxiv2021
33564789Immuno-fibrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2 infection (PASC).medRxiv2021
33635335A neutrophil activation signature predicts critical illness and mortality in COVID-19.Blood Adv2021
34410530Chronic Thromboembolic Pulmonary Hypertension: the Bedside.Curr Cardiol Rep2021
34410515Chronic Thromboembolic Pulmonary Hypertension: the Bench.Curr Cardiol Rep2021
34506735Hospitalisation among vaccine breakthrough COVID-19 infections.Lancet Infect Dis2021
33991637Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.J Hepatol2021
33966492Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients.Stroke2021
34248990Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19.Front Immunol2021
34145437Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19.Nat Med2021
34281793Association of obesity with venous thromboembolism and myocardial injury in COVID-19.Obes Res Clin Pract2021
34111030Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection.JCI Insight2021
34358229Challenges in interpreting cytokine data in COVID-19 affect patient care and management.PLoS Biol2021
33214651Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.Nat Rev Cardiol2021
33476420Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis.Am J Hematol2021
33129886The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases.J Allergy Clin Immunol2021
32619411Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.Lancet Haematol2020
33282193Circulating markers of angiogenesis and endotheliopathy in COVID-19.Pulm Circ2020
33398292Changes in inflammatory and immune drivers in response to immunomodulatory therapies in COVID-19.medRxiv2020
32637968Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19.medRxiv2020
32577678Decreased plasma levels of the survival factor renalase are associated with worse outcomes in COVID-19.medRxiv2020
32702536Aortic valve calcification predicts all-cause mortality independent of coronary calcification and severe stenosis.Atherosclerosis2020
30984767MEF2 and the Right Ventricle: From Development to Disease.Front Cardiovasc Med2019
31236974The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.Ann N Y Acad Sci2019
30106596Therapeutic Engagement of the Histone Deacetylase IIA-Myocyte Enhancer Factor 2 Axis Improves Experimental Pulmonary Hypertension.Am J Respir Crit Care Med2018
27648944Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words.Am J Respir Crit Care Med2017
28437443Relative predictive value of lung cancer screening CT versus myocardial perfusion attenuation correction CT in the evaluation of coronary calcium.PLoS One2017
28356442Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension.Circulation2017
28430547Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.Am J Respir Crit Care Med2017
28964631A Tale of Two Elabela Null Mice.Trends Endocrinol Metab2017
28566713A PPARγ-dependent miR-424/503-CD40 axis regulates inflammation mediated angiogenesis.Sci Rep2017
28904225Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects.Sci Transl Med2017
28653904Reply: Transforming Growth Factor β1- and Bone Morphogenetic Protein 2/PPARγ-regulated MicroRNAs in Pulmonary Arterial Hypertension.Am J Respir Crit Care Med2017
27834690Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1β Production.Arterioscler Thromb Vasc Biol2017
27068353MicroRNA 139-5p coordinates APLNR-CXCR4 crosstalk during vascular maturation.Nat Commun2016
26888314miR-182 Modulates Myocardial Hypertrophic Response Induced by Angiogenesis in Heart.Sci Rep2016
25336633Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.Circulation2015
26169651Letter by Papangeli et al Regarding Article, "The ERG-APLNR Axis Controls Pulmonary Venule Endothelial Proliferation in Pulmonary Veno-Occlusive Disease".Circulation2015
26029832Elafin in pulmonary arterial hypertension. Beyond targeting elastases.Am J Respir Crit Care Med2015
24311379Essential role of Apelin signaling during lymphatic development in zebrafish.Arterioscler Thromb Vasc Biol2014
24315207Endothelium as a gatekeeper of fatty acid transport.Trends Endocrinol Metab2014
22294346Severe obstructive sleep apnea increases mortality in patients with ischemic heart disease and myocardial injury.Sleep Breath2013
  • 1 - 50 of 74

Recommended Authors

Katherine A Cottrill
Emory University
Career Start Year 2012
Number of shared co-authors 1
Jessica Minnier
Louis Stokes Cleveland VA Medical Center Cleveland
Career Start Year 2010
Number of shared co-authors 0
Saurabh Aggarwal
University of Alabama at Birmingham
Career Start Year 2009
Number of shared co-authors 0
Vikram Agarwal
University of Washington
Career Start Year 2008
Number of shared co-authors 0
Shruti Sharma
Postgraduate Institute of Medical Education and Research (PGIMER)
Career Start Year 2007
Number of shared co-authors 0
Nuala J Meyer
University of Pennsylvania Philadelphia
Career Start Year 2006
Number of shared co-authors 1
Amanda Graveline
Wyss Institute for Biologically Inspired Engineering
Career Start Year 2006
Number of shared co-authors 0
Victoria N Parikh
Stanford University
Career Start Year 2005
Number of shared co-authors 3
Liang Guo
CVPath Institute
Career Start Year 2004
Number of shared co-authors 0
Jamie R Privratsky
Durham VA and Duke University Medical Center
Career Start Year 2003
Number of shared co-authors 0
Yingze Zhang
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 4
Mete Civelek
Center for Public Health Genomics, University of Virginia
Career Start Year 2002
Number of shared co-authors 0
Mingyi Wang
National Cancer Institute
Career Start Year 2002
Number of shared co-authors 0
Samir M Parikh
The Ohio State University Wexner Medical Center
Career Start Year 2002
Number of shared co-authors 1
Arun Padmanabhan
Gladstone Institutes San Francisco
Career Start Year 2001
Number of shared co-authors 0
Mark S Segal
University of Florida
Career Start Year 2001
Number of shared co-authors 0
Rajeev Malhotra
Massachusetts General Hospital.
Career Start Year 2000
Number of shared co-authors 1
William M Oldham
Harvard Medical School
Career Start Year 2000
Number of shared co-authors 2
Mohit Jain
Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW
Career Start Year 2000
Number of shared co-authors 2
Gangjian Qin
University of Alabama at Birmingham, 1670 University Boulevard
Career Start Year 1999
Number of shared co-authors 0
Stephane Heymans
Maastricht University Medical Centre
Career Start Year 1998
Number of shared co-authors 0
Rebecca M Baron
Brigham and Women's Hospital
Career Start Year 1997
Number of shared co-authors 0
Roy L Sutliff
National Institutes of Health, and Blood Institute
Career Start Year 1994
Number of shared co-authors 0
Neal L Weintraub
Medical College of Georgia, Augusta University
Career Start Year 1993
Number of shared co-authors 0
Muredach P Reilly
Vagelos College of Physicians and Surgeons, Columbia University
Career Start Year 1992
Number of shared co-authors 1
Jennifer L Hall
Institute for Precision Cardiovascular Medicine
Career Start Year 1992
Number of shared co-authors 1
Allen D Everett
Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 1
Gary H Gibbons
and Blood Institute
Career Start Year 1983
Number of shared co-authors 0
Kenneth Walsh
University of Virginia School of Medicine
Career Start Year 1982
Number of shared co-authors 3
Daniel Cruz
University of California Los Angeles
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Alfred I Lee
Yale University School of Medicine
Co-authored papers 19
Irinna Papangeli
Co-authored papers 12
Thomas Quertermous
Co-authored papers 11
Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
Co-authored papers 6
Henry M Rinder
Yale School of Medicine
Co-authored papers 6
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Co-authored papers 5
Euan A Ashley
Stanford University
Co-authored papers 4
Jennifer M Kwan
Yale School of Medicine
Co-authored papers 4
Jonathan M Siner
Yale University School of Medicine
Co-authored papers 3
David van Dijk
Yale School of Medicine, Yale University
Co-authored papers 3
Jason Bishai
Yale University
Co-authored papers 3
Michael Simonov
Clinical and Translational Research Accelerator, Yale University
Co-authored papers 3
Sudarshan Rajagopal
Co-authored papers 3
Stephen Y Chan
and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine
Co-authored papers 3
Katharine R Clapham
Co-authored papers 2
Donna Neuberg
Co-authored papers 2
Albert I Ko
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers 2
Patrick Yue
Former employee of Portola Pharmaceuticals
Co-authored papers 2
Akiko Iwasaki
Yale University
Co-authored papers 2
Daniel G Anderson
Co-authored papers 2
Maria E Sundaram
Dalla Lana School of Public Health, University of Toronto
Co-authored papers 1
Paul A Heidenreich
Stanford University School of Medicine
Co-authored papers 1
Carolina Lucas
Yale School of Medicine
Co-authored papers 1
Jiefang Huang
College of Life and Environmental Sciences, Hangzhou Normal University
Co-authored papers 1
John H Alexander
Duke University Medical Center
Co-authored papers 1
Nishant R Shah
Brown University Alpert Medical School
Co-authored papers 1
Roy S Herbst
Yale School of Medicine
Co-authored papers 1
Adam J Moore
Yale School of Public Health
Co-authored papers 1
C-Hong Chang
Yale University School of Medicine
Co-authored papers 1
Andrew Wang
Yale University School of Medicine
Co-authored papers 1
Release 1.2